0
Quality of Life in Individuals With Anxiety Disorders
Mauro V. Mendlowicz, M.D.; Murray B. Stein, M.D.
Cytokines and the Brain: Implications for Clinical Psychiatry
Ziad Kronfol, M.D.; Daniel G. Remick, M.D.
Dementia in Elderly Persons in a General Hospital
Constantine G. Lyketsos, M.D., M.H.S.; Jeannie-Marie E. Sheppard, B.A.; Peter V. Rabins, M.D., M.P.H.
Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging
Constantine G. Lyketsos, M.D., M.H.S.; Martin Steinberg, M.D.; JoAnn T. Tschanz, Ph.D.; Maria C. Norton, M.S.; David C. Steffens, M.D.; John C.S. Breitner, M.D., M.P.H.
Vitamin B12 Deficiency and Depression in Physically Disabled Older Women: Epidemiologic Evidence From the Women’s Health and Aging Study
Brenda W.J.H. Penninx, Ph.D.; Jack M. Guralnik, M.D., Ph.D.; Luigi Ferrucci, M.D., Ph.D.; Linda P. Fried, M.D., Ph.D.; Robert H. Allen, M.D.; Sally P. Stabler, M.D.
Comorbid Anxiety Disorders in Depressed Elderly Patients
Eric J. Lenze, M.D.; Benoit H. Mulsant, M.D.; M. Katherine Shear, M.D.; Herbert C. Schulberg, Ph.D.; Mary Amanda Dew, Ph.D.; Amy E. Begley, M.A.; Bruce G. Pollock, M.D., Ph.D.; Charles F. Reynolds, III, M.D.
Comparison of Sertraline and Nortriptyline in the Treatment of Major Depressive Disorder in Late Life
William Bondareff, M.D., Ph.D.; Murray Alpert, Ph.D.; Arnold J. Friedhoff, M.D.; Ellen M. Richter, Ph.D.; Cathryn M. Clary, M.D.; Evan Batzar, M.S.
Hippocampal Volume in Adolescent-Onset Alcohol Use Disorders
Michael D. De Bellis, M.D.; Duncan B. Clark, M.D., Ph.D.; Sue R. Beers, Ph.D.; Paul H. Soloff, M.D.; Amy M. Boring, B.S.; Julie Hall, B.A.; Adam Kersh, B.A.; Matcheri S. Keshavan, M.D.
Age at First Alcohol Use: A Risk Factor for the Development of Alcohol Disorders
David J. DeWit, Ph.D.; Edward M. Adlaf, Ph.D.; David R. Offord, M.D.; Alan C. Ogborne, Ph.D.
Prospective Study of Depression and the Risk of Heavy Alcohol Use in Women
Anita R. Dixit, M.H.S.; Rosa M. Crum, M.D., M.H.S.
Central Auditory Processing in Patients With Auditory Hallucinations
Colette M. McKay, Ph.D.; Donna M. Headlam, M.Sc.; David L. Copolov, M.B., Ph.D.
Normal P50 Suppression in Schizophrenia Patients Treated With Atypical Antipsychotic Medications
Gregory A. Light, B.A.; Mark A. Geyer, Ph.D.; Brett A. Clementz, Ph.D.; Kristin S. Cadenhead, M.D.; David L. Braff, M.D.
Visual Perception and Working Memory in Schizotypal Personality Disorder
Carrie M. Farmer, B.A.; Brian F. O’Donnell, Ph.D.; Margaret A. Niznikiewicz, Ph.D.; Martina M. Voglmaier, Ph.D.; Robert W. McCarley, M.D.; Martha E. Shenton, Ph.D.
Verbal and Nonverbal Neuropsychological Test Performance in Subjects With Schizotypal Personality Disorder
Martina M. Voglmaier, Ph.D.; Larry J. Seidman, Ph.D.; Margaret A. Niznikiewicz, Ph.D.; Chandlee C. Dickey, M.D.; Martha E. Shenton, Ph.D.; Robert W. McCarley, M.D.
Premorbid Speech and Language Impairments in Childhood-Onset Schizophrenia: Association With Risk Factors
Rob Nicolson, M.D.; Marge Lenane, M.S.W.; Sujatha Singaracharlu, M.D.; Dolores Malaspina, M.D.; Jay N. Giedd, M.D.; Susan D. Hamburger, M.A., M.S.; Peter Gochman, M.A.; Jeffrey Bedwell, B.S.; Gunvant K. Thaker, M.D.; Tom Fernandez, B.S.; Marianne Wudarsky, M.D., Ph.D.; Daniel W. Hommer, M.D.; Judith L. Rapoport, M.D.
Obstetric Risk Factors for Early-Onset Schizophrenia in a Finnish Birth Cohort
Isabelle M. Rosso, M.A.; Tyrone D. Cannon, Ph.D.; Tiia Huttunen, M.A.; Matti O. Huttunen, M.D., Ph.D.; Jouko L�vist, M.D., Ph.D.; Timothy L. Gasperoni, M.A.
Untreated Initial Psychosis: Its Relation to Quality of Life and Symptom Remission in First-Episode Schizophrenia
Beng-Choon Ho, M.R.C.Psych.; Nancy C. Andreasen, M.D., Ph.D.; Michael Flaum, M.D.; Peg Nopoulos, M.D.; Del Miller, Pharm.D., M.D.
Divalproex Treatment for Youth With Explosive Temper and Mood Lability: A Double-Blind, Placebo-Controlled Crossover Design
Stephen J. Donovan, M.D.; Jonathan W. Stewart, M.D.; Edward V. Nunes, M.D.; Frederic M. Quitkin, M.D.; Michael Parides, Ph.D.; William Daniel, C.S.W.; Ezra Susser, M.D., Dr.P.H.; Donald F. Klein, M.D.
Response to Flumazenil in Women With Premenstrual Dysphoric Disorder
Jean-Michel Le Mellédo, M.D.; Michelle Van Driel, M.D.; Nicholas John Coupland, M.D.; Paula Lott, M.D.; Gian S. Jhangri, M.Sc.
Adhesio Interthalamica in Male Patients With Schizophrenia
Eva M. Meisenzahl, M.D.; Thomas Frodl, M.D.; Thomas Zetzsche, M.D.; Gerda Leinsinger, M.D.; Dirk Heiss, M.D.; Klaus Maag, M.D.; Ulrich Hegerl, M.D.; Klaus Hahn, M.D.; Hans-Jürgen Möller, M.D.
Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia
A. Eden Evins, M.D.; Sandra M. Fitzgerald, M.D.; Lara Wine, B.S.; Roseanne Rosselli, B.A.; Donald C. Goff, M.D.
Reduced Olfactory Bulb Volume in Patients With Schizophrenia
Bruce I. Turetsky, M.D.; Paul J. Moberg, Ph.D.; David M. Yousem, M.D.; Richard L. Doty, Ph.D.; Steven E. Arnold, M.D.; Raquel E. Gur, M.D., Ph.D.
Low GSK-3ß Immunoreactivity in Postmortem Frontal Cortex of Schizophrenic Patients
Nitsan Kozlovsky, Ph.D.; R.H. Belmaker, M.D.; Galila Agam, Ph.D.
Amphetamine Misuse and Social Phobia
KELWYN WILLIAMS, M.R.C.PSYCH.; SPILIOS ARGYROPOULOS, M.SC., M.R.C.PSYCH.; DAVID J. NUTT, D.M., M.R.C.P., F.R.C.PSYCH.
Focal Segmental Glomerulosclerosis and Lithium Treatment
ANDREAS SCHREINER, M.D.; RÜDIGER WALDHERR, M.D.; PETER ROHMEISS, M.D.; WALTER HEWER, M.D.
Euphoric Mania and Rapid Transcranial Magnetic Stimulation
ANDREAS ERFURTH, M.D.; NIKOLAUS MICHAEL, M.D.; CHRISTIAN MOSTERT, M.D.; VOLKER AROLT, M.D.
Ziprasidone Overdose
SIMON BURTON, M.B., CH.B., B.MED.SCI., F.R.A.N.Z.C.P.; KAREN HESLOP, B.N., GRAD.DIP., M.ED.; KERRY HARRISON, B.SCI., R.N.; MARK BARNES, M.B., CH.B., F.R.A.N.Z.C.P.
Antidepressant-Induced Sexual Dysfunction and Ginkgo Biloba
ADAM KELLER ASHTON, M.D.; KRISTIN AHRENS, M.D.; SANJAY GUPTA, M.D.; PRAKASH S. MASAND, M.D.
Racial Differences in Treatment of Adolescents With Bipolar Disorder
MELISSA P. DELBELLO, M.D.; CESAR A. SOUTULLO, M.D.; STEPHEN M. STRAKOWSKI, M.D.
Treatments to Change Sexual Orientation
FRED S. BERLIN, M.D., PH.D.
Biology Versus Psychoanalysis
NEIL SCHEURICH, M.D.
Dr. Goldsmith and Colleagues Reply
TOBY D. GOLDSMITH, M.D.; NATHAN A. SHAPIRA, M.D.; PAUL E. KECK, JR., M.D.
Possible Interaction of Tramadol and Antidepressants
VICTOR I. REUS, M.D.; LEE RAWITSCHER, M.D.
Dr. Pallanti Replies
STEFANO PALLANTI, M.D., PH.D.
Use of ECT in Italy
RICHARD ABRAMS, M.D.
Cognition: Mental Rotation
Apostolos P. Georgopoulos, M.D., Ph.D.
Karl Kleist, 1879–1960
Andreas Joachim Bartsch, M.D.; Klaus-Jürgen Neumärker, M.D.; Ernst Franzek, M.D.; Helmut Beckmann, M.D.